美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE	078709	003	ANDA	GLIMEPIRIDE; ROSIGLITAZONE MALEATE	TABLET;ORAL	4MG;4MG	No	No	2016/04/01	2016/04/01	TEVA PHARMS USA	Discontinued
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE	078709	004	ANDA	GLIMEPIRIDE; ROSIGLITAZONE MALEATE	TABLET;ORAL	2MG;8MG	No	No	2016/04/01	2016/04/01	TEVA PHARMS USA	Discontinued
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE	078709	005	ANDA	GLIMEPIRIDE; ROSIGLITAZONE MALEATE	TABLET;ORAL	4MG;8MG	No	No	2016/04/01	2016/04/01	TEVA PHARMS USA	Discontinued
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE	077337	001	ANDA	METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE	TABLET;ORAL	500MG;EQ 2MG BASE	No	No	2017/05/19	2014/05/07	TEVA	Discontinued
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE	077337	002	ANDA	METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE	TABLET;ORAL	500MG;EQ 4MG BASE	No	No	2017/05/19	2014/05/07	TEVA	Discontinued
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE	077337	003	ANDA	METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE	TABLET;ORAL	1GM;EQ 2MG BASE	No	No	2017/05/19	2014/05/07	TEVA	Discontinued
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE	077337	004	ANDA	METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE	TABLET;ORAL	1GM;EQ 4MG BASE	No	No	2017/05/19	2014/05/07	TEVA	Discontinued
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE	077337	005	ANDA	METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE	TABLET;ORAL	500MG;EQ 1MG BASE	No	No	2017/05/19	2017/05/19	TEVA	Discontinued